{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:46:50Z","timestamp":1787021210535,"version":"build-2736575974"},"reference-count":18,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,1]]},"DOI":"10.1210\/jc.2018-00054","type":"journal-article","created":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T14:03:07Z","timestamp":1521727387000},"page":"2277-2283","source":"Crossref","is-referenced-by-count":12,"title":["Urine and Serum Sex Steroid Profile in Testosterone-Treated Transgender and Hypogonadal and Healthy Control Men"],"prefix":"10.1210","volume":"103","author":[{"given":"Sasha","family":"Savkovic","sequence":"first","affiliation":[{"name":"Andrology Department, Concord Hospital, ANZAC Research Institute, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarina","family":"Lim","sequence":"additional","affiliation":[{"name":"Andrology Department, Concord Hospital, ANZAC Research Institute, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veena","family":"Jayadev","sequence":"additional","affiliation":[{"name":"Andrology Department, Concord Hospital, ANZAC Research Institute, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Conway","sequence":"additional","affiliation":[{"name":"Andrology Department, Concord Hospital, ANZAC Research Institute, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Turner","sequence":"additional","affiliation":[{"name":"Andrology Department, Concord Hospital, ANZAC Research Institute, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Curtis","sequence":"additional","affiliation":[{"name":"Australian Sports Drug Testing Laboratory, National Measurement Institute, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catrin","family":"Goebel","sequence":"additional","affiliation":[{"name":"Australian Sports Drug Testing Laboratory, National Measurement Institute, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Handelsman","sequence":"additional","affiliation":[{"name":"Andrology Department, Concord Hospital, ANZAC Research Institute, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,3,22]]},"reference":[{"key":"2019041121272232500_B1","unstructured":"World Anti-Doping Agency . Medical information to support the decisions of TUECs - male hypogonadism. Available at: https:\/\/www.wada-ama.org\/en\/resources\/therapeutic-use-exemption-tue\/medical-information-to-support-the-decisions-of-tuecs-male. Accessed 9 April 2018."},{"key":"2019041121272232500_B2","unstructured":"World Anti-Doping Agency . Medical information to support the decisions of TUECs - transgender athletes. Available at: https:\/\/www.wada-ama.org\/en\/resources\/science-medicine\/medical-information-to-support-the-decisions-of-tuecs-female-to-male. Accessed 9 April 2018."},{"issue":"1\u20132","key":"2019041121272232500_B3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cca.2009.09.003","article-title":"Development and validation of a sensitive liquid chromatography\u2013tandem mass spectrometry assay to simultaneously measure androgens and estrogens in serum without derivatization","volume":"409","author":"Harwood","year":"2009","journal-title":"Clin Chim Acta"},{"issue":"14","key":"2019041121272232500_B4","doi-asserted-by":"crossref","first-page":"7180","DOI":"10.1021\/acs.analchem.5b01042","article-title":"Measurement of estradiol in human serum by LC-MS\/MS using a novel estrogen-specific derivatization reagent","volume":"87","author":"Keski-Rahkonen","year":"2015","journal-title":"Anal Chem"},{"issue":"4","key":"2019041121272232500_B5","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1210\/jc.2015-3810","article-title":"Temporal trend in androgen status and androgen-sensitive outcomes in older men","volume":"101","author":"Hsu","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"11\u201312","key":"2019041121272232500_B6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/dta.71","article-title":"Screening for testosterone abuse in male athletes using the measurement of urinary LH, a revision of the paradigm","volume":"1","author":"Goebel","year":"2009","journal-title":"Drug Test Anal"},{"key":"2019041121272232500_B7","unstructured":"World Anti-Doping Agency. Technical document for endogenous anabolic androgenic steroids (TD2016EAAS). Available at: https:\/\/www.wada-ama.org\/en\/resources\/science-medicine\/td2016eaas. Accessed 9 April 2018."},{"key":"2019041121272232500_B8","unstructured":"World Anti-Doping Agency. International Standard for Laboratories (ISL). Available at: https:\/\/www.wada-ama.org\/en\/resources\/laboratories\/international-standard-for-laboratories-isl. Accessed 9 April 2018."},{"key":"2019041121272232500_B9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jsbmb.2014.01.011","article-title":"Detection and effects on serum and urine steroid and LH of repeated GnRH analog (leuprolide) stimulation","volume":"141","author":"Handelsman","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4","key":"2019041121272232500_B10","first-page":"225","article-title":"Estimation of human body surface area from height and weight","volume":"54","author":"Gehan","year":"1970","journal-title":"Cancer Chemother Rep"},{"issue":"3\u20134","key":"2019041121272232500_B11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0378-5122(81)90028-1","article-title":"Production rates of androgens and oestrogens in post-menopausal women","volume":"3","author":"Longcope","year":"1981","journal-title":"Maturitas"},{"issue":"4","key":"2019041121272232500_B12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-8587(16)00036-X","article-title":"Testosterone therapy for transgender men","volume":"5","author":"Irwig","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"2019041121272232500_B13","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1530\/EJE-09-0412","article-title":"Safety aspects of 36 months of administration of long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals","volume":"161","author":"Jacobeit","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2019041121272232500_B14","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1210\/jc.2005-1643","article-title":"Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism","volume":"91","author":"Jakobsson","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2019041121272232500_B15","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1210\/jc.2008-0218","article-title":"Doping test results dependent on genotype of uridine diphospho-glucuronosyl transferase 2B17, the major enzyme for testosterone glucuronidation","volume":"93","author":"Schulze","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041121272232500_B16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ajhg.2008.08.004","article-title":"Adaptive evolution of UGT2B17 copy-number variation","volume":"83","author":"Xue","year":"2008","journal-title":"Am J Hum Genet"},{"issue":"6","key":"2019041121272232500_B17","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1046\/j.1365-2265.1999.00881.x","article-title":"Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men","volume":"51","author":"Nieschlag","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121272232500_B18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.urology.2017.07.007","article-title":"Initial clinical experience with testosterone undecanoate therapy (AVEED) in men with testosterone deficiency in the United States","volume":"109","author":"Krakowsky","year":"2017","journal-title":"Urology"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/103\/6\/2277\/25011469\/jc.2018-00054.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T14:57:35Z","timestamp":1693580255000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/103\/6\/2277\/4947772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,22]]},"references-count":18,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,3,22]]},"published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2018-00054","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,6]]},"published":{"date-parts":[[2018,3,22]]}}}